XRP0038/NV1FGF

· Sanofi

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XRP0038/NV1FGF, covering 2016-05-02 to 2016-05-02. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions [Phase 3]